$Westinghouse Air Brake Technologies (WAB.US)$From 2019 to 2024, the revenue CGAR is 6.6%, the EPS CGAR is 12.6%. If early 2020 price level of 80 is used to project today’s share price based on EPS, the price would be 145. Forward P/E now is 188/8.55~21.9, which is right in line with SPX multiple. This stock’s P/E has been expanded by about 20% as SPX from 2019 to present. So the plan is buy on technical weakness if it drops to the 200 day ma or better at 160ish due to recent earnings miss. The ...
The market's opinion of the business has improved over the past five years, likely due to consistent earnings growth. Recent returns and share price momentum indicate positive sentiment. However, other factors, such as potential warning signs, should be considered for a comprehensive understanding of the company's performance.
Significant insider selling at Westinghouse Air Brake Technologies and lack of purchases in the last year may concern investors. Despite profitability and growth, share sales history could be worrisome. High insider ownership could indicate management's shareholder interest.
The company's consistent EPS growth and high level of insider ownership suggest that the management has faith in Westinghouse Air Brake Technologies' continuing strength. It is suggested that the business is worthy of further research for potential investors.
Despite its high P/E ratio, Westinghouse Air Brake Technologies is said to have convinced investors with its robust future growth that outshines the broader market. An earnings decrease doesn't seem to have a severe impact to its P/E ratio.
Spurred by cooler inflation data, the S&P 500 added to its year-end rally during Friday's trading session. Within the index, 37 stocks hit new 52-week highs. 13 of these names hit new all-time highs. Here's a look at the stocks that reached the milestone: $Booking Holdings (BKNG.US)$since its IPO in Apr, 1999 $Hilton Worldwide (HLT.US)$since its IPO in Dec, 2013 $AMETEK (AME.US)$since it began trading on the NYSE in 1930 $Axon Enterprise (AXON.US)$s...
Investments by the company appear not to generate high returns. Despite a 85% stock growth in the last five years, future potential as a multi-bagger is doubtful if trends persist.
The Week Ahead in Focus It's the peak stretch of second-quarter earnings season, with roughly 150 S&P 500 firms scheduled to report this week. The highlights on the economic calendar will be a pair of purchasing managers' index readings and jobs Friday. Economic data out this week will include the Institute for Supply Management's Manufacturing Purchasing Managers' Index for July on Monday, followed by the Services PMI on Wednesday. Both me...
Westinghouse Air Brake Technologies Stock Forum
So the plan is buy on technical weakness if it drops to the 200 day ma or better at 160ish due to recent earnings miss. The ...
LOW VOLUME EASY CONTROL PRICE WHY ME 😏
Within the index, 37 stocks hit new 52-week highs.
13 of these names hit new all-time highs. Here's a look at the stocks that reached the milestone:
$Booking Holdings (BKNG.US)$ since its IPO in Apr, 1999
$Hilton Worldwide (HLT.US)$ since its IPO in Dec, 2013
$AMETEK (AME.US)$ since it began trading on the NYSE in 1930
$Axon Enterprise (AXON.US)$ s...
It's the peak stretch of second-quarter earnings season, with roughly 150 S&P 500 firms scheduled to report this week. The highlights on the economic calendar will be a pair of purchasing managers' index readings and jobs Friday.
Economic data out this week will include the Institute for Supply Management's Manufacturing Purchasing Managers' Index for July on Monday, followed by the Services PMI on Wednesday. Both me...
• $Funko (FNKO.US)$ : JPMorgan Upgrades to Overweight from Neutral - PT $28 (from $25)
• $Southwest Airlines (LUV.US)$ : Raymond James Upgrades to Strong Buy from Outperform - PT $55 (from $57)
• $MetLife (MET.US)$ : Wolfe Research Upgrades to Outperform from Peerperform
• $MGIC Investment (MTG.US)$ : RBC Capital Upgrades to Outperform from Sector Perform - PT $16 (from $15)
• $Snowflake (SNOW.US)$ : JPMorgan Upgrades to Overweigh...
No comment yet